Health Care [ 12/12 ] | Life Sciences Tools & Services [ 71/74 ]
NASDAQ | Common Stock
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.
The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
The Life Sciences Products segment offers automated cold storage solutions, consumables and instruments, controlled rate thawing devices, and temperature-controlled storage and transportation solutions.
This segment also provides sample management solutions, such as consumable vials and tubes, polymerase chain reaction, plates, instruments for supporting workflows, and informatics.
The Life Sciences Services segment provides genomic services, that includes gene sequencing and gene synthesis services; and sample repository solutions, such as on-site and off-site sample storage, cold chain logistics, sample transport and collection relocation, bio-processing solutions, disaster recovery and business continuity, and biospecimen procurement services, as well as project management and consulting services for genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development sectors.
It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes.
The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021.
Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 6, 24 | 0.16 Increased by +23.08% | 0.07 Increased by +128.57% |
| May 8, 24 | 0.05 Increased by +183.33% | 0.02 Increased by +150.00% |
| Feb 7, 24 | 0.02 Decreased by -83.33% | -0.03 Increased by +166.67% |
| Nov 13, 23 | 0.13 Decreased by -18.75% | 0.02 Increased by +550.00% |
| Aug 8, 23 | 0.13 Increased by +8.33% | -0.02 Increased by +750.00% |
| May 9, 23 | -0.06 Decreased by -150.00% | -0.02 Decreased by -200.00% |
| Feb 8, 23 | 0.12 Increased by 0.00% | 0.08 Increased by +50.00% |
| Nov 14, 22 | 0.16 Decreased by -79.49% | 0.07 Increased by +128.57% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 24 | 172.81 M Increased by +4.13% | -6.58 M Decreased by -347.76% | Decreased by -3.81% Decreased by -329.98% |
| Mar 31, 24 | 159.13 M Increased by +7.23% | -136.88 M Decreased by -6.77 K% | Decreased by -86.02% Decreased by -6.31 K% |
| Dec 31, 23 | 154.32 M Decreased by -13.48% | -15.72 M Decreased by -39.96% | Decreased by -10.19% Decreased by -61.77% |
| Sep 30, 23 | 172.36 M Increased by +25.29% | 3.38 M Increased by +163.56% | Increased by +1.96% Increased by +150.73% |
| Jun 30, 23 | 165.95 M Increased by +25.02% | -1.47 M Increased by +79.04% | Decreased by -0.89% Increased by +83.24% |
| Mar 31, 23 | 148.40 M Increased by +1.96% | -1.99 M Decreased by -9.64% | Decreased by -1.34% Decreased by -7.53% |
| Dec 31, 22 | 178.37 M Increased by +27.72% | -11.23 M Decreased by -125.93% | Decreased by -6.30% Decreased by -120.31% |
| Sep 30, 22 | 137.57 M Increased by +0.46% | -5.31 M Decreased by -124.35% | Decreased by -3.86% Decreased by -124.24% |